Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006, Article ID 36376, 3 pages
http://dx.doi.org/10.1155/MI/2006/36376
Short Communication

The Quantitative Analysis of bFGF and VEGF by ELISA in Human Meningiomas

1UMR CNRS 6101, 2 rue du Dr. Marcland, Limoges 87025, France
2Service d'Anatomie Pathologique, CHU Dupuytren, 2 Avenue M. Luther King, Limoges 87045, France
3Service de Neurosurgery, CHU Dupuytren, 2 Avenue M. Luther King, Limoges 87045, France

Received 23 June 2006; Revised 3 September 2006; Accepted 10 September 2006

Copyright © 2006 Yves Denizot et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I R Whittle, C Smith, P Navoo, and D Collie, “Meningiomas,” The Lancet, vol. 363, no. 9420, pp. 1535–1543, 2004. View at Publisher · View at Google Scholar
  2. F Bussolino, A Albini, G Camussi et al., “Role of soluble mediators in angiogenesis,” European Journal of Cancer, vol. 32, no. 14, pp. 2401–2412, 1996. View at Publisher · View at Google Scholar
  3. M Nomura, S Yamagishi, S Harada, T Yamashima, J Yamashita, and H Yamamoto, “Placenta growth factor (PlGF) mRNA expression in brain tumors,” Journal of Neuro-Oncology, vol. 40, no. 2, pp. 123–130, 1998. View at Publisher · View at Google Scholar
  4. K Samoto, K Ikezaki, M Ono et al., “Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors,” Cancer Research, vol. 55, no. 5, pp. 1189–1193, 1995. View at Google Scholar
  5. T Pietsch, M M Valter, H K Wolf et al., “Expression and distribution of vascular endothelial growth factor protein in human brain tumors,” Acta Neuropathologica, vol. 93, no. 2, pp. 109–117, 1997. View at Publisher · View at Google Scholar
  6. M Landriscina, A Cassano, C Ratto et al., “Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer,” British Journal of Cancer, vol. 78, no. 6, pp. 765–770, 1998. View at Google Scholar
  7. M Mathonnet, B Descottes, D Valleix, F Labrousse, V Truffinet, and Y Denizot, “Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer, liver metastasis of colorectal cancer and hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 12, no. 23, pp. 3782–3783, 2006. View at Google Scholar
  8. Y Denizot, T Chianéa, F Labrousse, V Truffinet, M Delage, and M Mathonnet, “Platelet-activating factor and human thyroid cancer,” European Journal of Endocrinology, vol. 153, no. 1, pp. 31–40, 2005. View at Publisher · View at Google Scholar
  9. P Kleihues and W K Cavenee, Eds., Pathology and Genetics of Tumours of the Nervous System. World Health Organization Classification of Tumours, IARC Press, Lyon, France, 2000.
  10. K Lamszus, U Lengler, N O Schmidt, D Stavrou, S Ergün, and M Westphal, “Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy,” Neurosurgery, vol. 46, no. 4, pp. 938–948, 2000. View at Publisher · View at Google Scholar
  11. C K Goldman, S Bharara, C A Palmer et al., “Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression,” Neurosurgery, vol. 40, no. 6, pp. 1269–1277, 1997. View at Publisher · View at Google Scholar